Guardian Pharmacy Services Target Price

See Guardian Pharmacy Services's analyst price targets ($51) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$39.44

Average Target Price

$50.67

28.5% upside

3 analysts in the last 4 months

High: $52 | Low: $49

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-22	KeyBanc	$52	31.8% upside
2026-09-21	Truist Financial	$51	29.3% upside
2026-08-07	Oppenheimer	$49	24.2% upside
2026-06-17	Truist Financial	$47	19.2% upside
2026-03-12	Raymond JamesJohn Ransom	$40	1.4% upside
2026-03-12	Truist FinancialDavid MacDonald	$38	3.7% downside
2026-01-14	StephensRaj Kumar	$36	8.7% downside
2025-11-14	Truist Financial	$34	13.8% downside
2025-10-10	Oppenheimer	$30	23.9% downside
2025-09-26	Truist FinancialDavid MacDonald	$30	23.9% downside
2025-05-14	Raymond JamesJohn Ransom	$28	29% downside

Guardian Pharmacy Services (GRDN) FAQ

As of the most recent data, GRDN shows a target price of $51. Scroll down for historical charts and peer comparison views.

If Guardian Pharmacy Services moved to the average analyst target of $51, shares would be roughly 28.5% higher than $39.44. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Guardian Pharmacy Services's earnings trajectory.

Besides this target price page, Stockcircle has Guardian Pharmacy Services's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $51) with ownership activity and broader fundamentals.